Partner Content Partner Content 6th Annual Next Generation Sequencing USA Congress 2 days, 350+ end users, 80+ case studies
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
